CNTA · Centessa Pharmaceuticals plc · Share Buybacks

Market Cap

$6.27B

154.73M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Remaining Authorization

2,708,615 shares

as of 2026-03-31

Equity Offering (ATM) Programs

Program Established	Last Amended	Capacity	Sold	Remaining	Runs Through	Source
2023-01-27	2025-11-24	$250,000,000	—	—	—	8-K , filed 2025-11-24
—	2025-11	$250,000,000	—	—	—	10-Q , filed 2026-05-05

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2021-01-29 YTD	$0	—	—	10-Q, filed 2021-11-15
2020-12-31	$0	—	—	10-K, filed 2022-03-30
2019-12-31	$0	—	—	10-K, filed 2022-03-30

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2021-12-31	$0 Δ	—	—	10-K, filed 2022-03-30
2021-09-30	$0 Δ	—	—	10-Q, filed 2021-11-15
2020-12-31	$0 Δ	—	—	10-K, filed 2022-03-30
2020-09-30	$0 Δ	—	—	10-Q, filed 2021-11-15

Key facts CIK 1847903 CUSIP 152309100 Visit website